review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Sara De Biasi | Q82958176 |
Lara Gibellini | Q114404433 | ||
Erika Roat | Q117266261 | ||
Linda Bertoncelli | Q117266266 | ||
Jonas P Montagna | Q117266267 | ||
Marcello Pinti | Q41701743 | ||
Milena Nasi | Q38804449 | ||
Andrea Cossarizza | Q38804464 | ||
P2093 | author name string | Edwin L Cooper | |
P2860 | cites work | PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes | Q22008738 |
Oxidative Decay of DNA | Q22066181 | ||
A model for p53-induced apoptosis | Q24313374 | ||
Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells | Q24319922 | ||
Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement | Q24642324 | ||
Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage | Q24651327 | ||
Mechanism of human SIRT1 activation by resveratrol | Q28238262 | ||
Flavonols and pancreatic cancer risk: the multiethnic cohort study | Q28240121 | ||
Flavonoids: antioxidants or signalling molecules? | Q28250292 | ||
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors | Q28282622 | ||
Dietary flavonoids induce MLL translocations in primary human CD34+ cells | Q28299881 | ||
Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion | Q28371910 | ||
Mammalian sirtuins: biological insights and disease relevance | Q29614496 | ||
Cancer chemoprevention with dietary phytochemicals | Q29617743 | ||
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies | Q29617784 | ||
The antioxidant function of the p53 tumor suppressor | Q29619231 | ||
Epidemiology of lung cancer: looking to the future. | Q30350696 | ||
Antioxidant chemistry of green tea catechins. New oxidation products of (-)-epigallocatechin gallate and (-)-epigallocatechin from their reactions with peroxyl radicals. | Q30613149 | ||
A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties | Q31121766 | ||
Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. | Q32049448 | ||
Characterization of cells with different mitochondrial membrane potential during apoptosis | Q33223961 | ||
Cost effectiveness of natural health products: a systematic review of randomized clinical trials | Q33379761 | ||
Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometry | Q33518424 | ||
Analysis of tea polyphenols | Q33593301 | ||
Flavonoid intake and risk of chronic diseases | Q33961042 | ||
Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols | Q33967930 | ||
Dietary intake and bioavailability of polyphenols | Q33985768 | ||
Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability | Q33994481 | ||
Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study | Q34099177 | ||
Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. | Q34146784 | ||
Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product | Q77799982 | ||
Decreased B16F10 melanoma growth and impaired tumour vascularization in BDF1 mice with quercetin-cyclodextrin binary system | Q79224263 | ||
Suppression of tumor growth and invasion in 9,10 dimethyl benz(a) anthracene induced mammary carcinoma by the plant bioflavonoid quercetin | Q79920810 | ||
Flavonoid intake and colorectal cancer risk in men and women | Q80148268 | ||
A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer | Q80244055 | ||
Role of p53 in antioxidant defense of HPV-positive cervical carcinoma cells following H2O2 exposure | Q80475029 | ||
Antioxidative and prooxidative effects of quercetin on A549 cells | Q80510195 | ||
Liposomal quercetin efficiently suppresses growth of solid tumors in murine models | Q83364602 | ||
p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. | Q40571016 | ||
Quercetin in our diet: from potent mutagen to probable anticarcinogen | Q40655710 | ||
Tumor promotion by hydrogen peroxide in rat liver epithelial cells | Q40962781 | ||
Dietary flavonoid intake and lung cancer--a population-based case-control study. | Q41277914 | ||
Cranberry and grape seed extracts inhibit the proliferative phenotype of oral squamous cell carcinomas | Q41788832 | ||
Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease | Q41975964 | ||
Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis In Vitro and In Vivo | Q42009141 | ||
Carcinogenicity examination of quercetin and rutin in ACI rats | Q42471811 | ||
In vitro cytotoxic effect of Brazilian green propolis on human laryngeal epidermoid carcinoma (HEp-2) cells | Q42662497 | ||
Ethanolic Extract of Propolis Augments TRAIL-Induced Apoptotic Death in Prostate Cancer Cells | Q42822464 | ||
Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. | Q43002840 | ||
Intake of flavonols and flavones and risk of coronary heart disease in male smokers | Q43515477 | ||
Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups | Q43548576 | ||
Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin | Q43573411 | ||
Flavonoid glucuronides are substrates for human liver beta-glucuronidase | Q43713502 | ||
Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin | Q43866518 | ||
Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis | Q43938062 | ||
Reactive oxygen species stimulated human hepatoma cell proliferation via cross-talk between PI3-K/PKB and JNK signaling pathways | Q44166293 | ||
International renal cell cancer study. VII. Role of diet | Q44173069 | ||
Perturbation of microtubule polymerization by quercetin through tubulin binding: a novel mechanism of its antiproliferative activity | Q44186752 | ||
Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism | Q44277902 | ||
Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation | Q44546815 | ||
The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis. | Q44673144 | ||
Consumption of vegetables and fruit and the risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition | Q44689781 | ||
Cytotoxicity of flavonoids toward cultured normal human cells | Q45246526 | ||
A mechanism-based antioxidant approach for the reduction of skin carcinogenesis | Q45285576 | ||
Cruciferous vegetables in relation to renal cell carcinoma. | Q45947701 | ||
Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. | Q46034803 | ||
Nanoencapsulation of quercetin enhances its dietary efficacy in combating arsenic-induced oxidative damage in liver and brain of rats | Q46226798 | ||
Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation | Q46267730 | ||
Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells | Q46387103 | ||
Vesicular flavonoid in combating diethylnitrosamine induced hepatocarcinoma in rat model. | Q46390126 | ||
Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon | Q46410328 | ||
Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). | Q46438701 | ||
Flavonoid intake and risk of pancreatic cancer in male smokers (Finland). | Q46694723 | ||
Quercetin in w/o microemulsion: in vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo | Q46730092 | ||
The reversibility of the glutathionyl-quercetin adduct spreads oxidized quercetin-induced toxicity | Q46771640 | ||
Flavonoids and the risk of renal cell carcinoma | Q46786814 | ||
Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells | Q46794275 | ||
The effects of quercetin on antioxidant status and tumor markers in the lung and serum of mice treated with benzo(a)pyrene | Q46867649 | ||
Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection | Q48169090 | ||
Food groups and renal cell carcinoma: a case-control study from Italy. | Q50717406 | ||
Prevention of 1,2-dimethylhydrazine-induced circulatory oxidative stress by bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione during colon carcinogenesis. | Q53346186 | ||
Effects of UV light and tumor promoters on endogenous vitamin E status in mouse skin. | Q53414068 | ||
Dietary antioxidants and lung cancer risk: a case-control study in Uruguay. | Q53420087 | ||
Lack of carcinogenicity of quercetin in F344/DuCrj rats. | Q53516118 | ||
NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells. | Q53581939 | ||
Flavonoids of cocoa inhibit recombinant human 5-lipoxygenase. | Q54319903 | ||
Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. | Q54463937 | ||
Polyphenols: Chemistry, Dietary Sources, Metabolism, and Nutritional Significance | Q56610830 | ||
Dietary Flavonoids and the Risk of Colorectal Cancer | Q57569947 | ||
Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers | Q58204790 | ||
Induction of sperm abnormalities in mice by quercetin | Q69720411 | ||
Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands | Q70517510 | ||
Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum) | Q71393634 | ||
Antioxidant activity of resveratrol in red wine | Q71581809 | ||
Time course of induction of rat hepatic drug-metabolizing enzyme activities following dietary administration of flavonoids | Q71901258 | ||
Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool | Q73086182 | ||
Dietary flavonoids: intake, health effects and bioavailability | Q73132209 | ||
Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women | Q73191054 | ||
Prooxidant activity of flavonoids: copper-dependent strand breaks and the formation of 8-hydroxy-2'-deoxyguanosine in DNA | Q73294746 | ||
Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential | Q74081784 | ||
Inhibition of xanthine oxidase by purpurogallin and silymarin group | Q74500768 | ||
Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties | Q74586431 | ||
Flavonoid antioxidants | Q34263068 | ||
The contribution of endogenous sources of DNA damage to the multiple mutations in cancer | Q34263814 | ||
Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound | Q34269720 | ||
Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses | Q34301424 | ||
Role of oxygen radicals in DNA damage and cancer incidence. | Q34383781 | ||
Review of the biology of Quercetin and related bioflavonoids | Q34401033 | ||
(-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma | Q34530415 | ||
The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. | Q34532264 | ||
Curcumin in cell death processes: a challenge for CAM of age-related pathologies | Q34580050 | ||
Prospective study of fruit and vegetable intake and risk of prostate cancer | Q34581329 | ||
Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition | Q34606105 | ||
Induction of apoptosis in human bladder cancer cells by green tea catechins | Q34611519 | ||
Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells | Q34612226 | ||
The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells | Q34615057 | ||
Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell Lines. | Q34667547 | ||
Induction of tumors in ACI rats given a diet containing ptaquiloside, a bracken carcinogen. | Q34688794 | ||
Molecular targets for nutrients involved with cancer prevention | Q34718681 | ||
Cancer prevention -- the potential for diet to modulate molecular signalling | Q35043753 | ||
Radical causes of cancer. | Q35097371 | ||
Aqueous Extract of Shi-Liu-Wei-Liu-Qi-Yin Induces G2/M Phase Arrest and Apoptosis in Human Bladder Carcinoma Cells via Fas and Mitochondrial Pathway | Q35102010 | ||
Assessment of the Antioxidant and Reactive Oxygen Species Scavenging Activity of Methanolic Extract of Caesalpinia crista Leaf. | Q35104965 | ||
Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes | Q35541796 | ||
Oxidative stress and cell signalling | Q35768393 | ||
Suppression of tumour development by substances derived from the diet--mechanisms and clinical implications | Q35803133 | ||
Flavonoids and breast cancer risk in Italy | Q36095499 | ||
Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects | Q36145133 | ||
Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1. | Q36202911 | ||
The roles of polyphenols in cancer chemoprevention | Q36528356 | ||
The quercetin paradox | Q36632544 | ||
Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention | Q36744963 | ||
Ins and outs of dietary phytochemicals in cancer chemoprevention. | Q36768726 | ||
Flavonoids: hemisynthesis, reactivity, characterization and free radical scavenging activity. | Q36982391 | ||
Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials | Q37160786 | ||
Perspectives for cancer prevention with natural compounds | Q37212228 | ||
Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences | Q37238526 | ||
Dietary patterns and breast cancer risk in women participating in the Black Women's Health Study | Q37309720 | ||
Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression | Q37330137 | ||
Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells. | Q37419562 | ||
Antihypertensive effects of the flavonoid quercetin | Q37421163 | ||
Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity | Q37432488 | ||
Differential growth suppression of human melanoma cells by tea (Camellia sinensis) epicatechins (ECG, EGC and EGCG). | Q38498201 | ||
Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway | Q39226135 | ||
Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5. | Q39748934 | ||
Induction of apoptosis by quercetin is mediated through AMPKalpha1/ASK1/p38 pathway | Q39750640 | ||
Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression | Q39794467 | ||
Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells | Q39799455 | ||
Protective mechanism of quercetin and rutin using glutathione metabolism on HO-induced oxidative stress in HepG2 cells | Q39805372 | ||
Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas | Q39841585 | ||
Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway | Q39851799 | ||
Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549. | Q39858365 | ||
Quercetin is able to demethylate the p16INK4a gene promoter | Q39922945 | ||
Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells | Q39923672 | ||
A novel antioxidant function for the tumor-suppressor gene p53 in the retinal ganglion cell | Q39980959 | ||
(-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway. | Q39982614 | ||
Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells | Q40005223 | ||
Quercetin induces cell cycle G1 arrest through elevating Cdk inhibitors p21 and p27 in human hepatoma cell line (HepG2). | Q40129163 | ||
Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). | Q40286264 | ||
Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity | Q40291546 | ||
Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin | Q40349362 | ||
Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis | Q40352598 | ||
Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression | Q40418488 | ||
Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression | Q40443907 | ||
Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells | Q40509371 | ||
Increased Nox1 and hydrogen peroxide in prostate cancer | Q40511475 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 591356 | |
P577 | publication date | 2011-04-14 | |
P1433 | published in | Evidence-based Complementary and Alternative Medicine | Q5418319 |
P1476 | title | Quercetin and cancer chemoprevention | |
P478 | volume | 2011 |
Q39339508 | 2'-Hydroxyflavanone induces apoptosis through Egr-1 involving expression of Bax, p21, and NAG-1 in colon cancer cells |
Q38614720 | A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer. |
Q35684276 | A Potent Inhibitor of Phosphoinositide 3-Kinase (PI3K) and Mitogen Activated Protein (MAP) Kinase Signalling, Quercetin (3, 3', 4', 5, 7-Pentahydroxyflavone) Promotes Cell Death in Ultraviolet (UV)-B-Irradiated B16F10 Melanoma Cells |
Q37729888 | A Specific Mixture of Nutrients Suppresses Ovarian Cancer A-2780 Tumor Incidence, Growth, and Metastasis to Lungs |
Q42374026 | Alzheimer Disease: Clues from traditional and complementary medicine |
Q47347078 | Ameliorative effects of gallic acid, quercetin and limonene on urethane-induced genotoxicity and oxidative stress in Drosophila melanogaster |
Q51527710 | Anti-cancer potential of flavonoids: recent trends and future perspectives. |
Q90581344 | Anti-tumor Effect of Quercetin Loaded Chitosan Nanoparticles on Induced Colon Cancer in Wistar Rats |
Q28076137 | Anticancer Efficacy of Polyphenols and Their Combinations |
Q39214234 | Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression |
Q40134887 | Anticancer and apoptosis‑inducing effects of quercetin in vitro and in vivo |
Q32186291 | Anticancer, antioxidant potential and profiling of polyphenolic compounds of Wrightia tinctoria Roxb. (R.Br.) bark |
Q37623396 | Antioxidant action and cytotoxicity on HeLa and NIH-3T3 cells of new quercetin derivatives |
Q36524660 | Antioxidant activities of licorice-derived prenylflavonoids |
Q42430023 | Antiproliferative activity of long chain acylated esters of quercetin-3-O-glucoside in hepatocellular carcinoma HepG2 cells |
Q95840325 | Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors |
Q86291066 | Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals |
Q38979880 | Biological evaluation and SAR analysis of O-methylated analogs of quercetin as inhibitors of cancer cell proliferation |
Q91679359 | Chemoprevention of Breast Cancer With Vitamins and Micronutrients: A Concise Review |
Q35116442 | Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6-hydroxydopamine |
Q37015444 | Combination chemoprevention with grape antioxidants |
Q39010120 | Combined treatment with quercetin and imperatorin as a potent strategy for killing HeLa and Hep-2 cells. |
Q43245104 | Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design. |
Q64076632 | Dietary Compounds as Epigenetic Modulating Agents in Cancer |
Q38818485 | Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges |
Q36214982 | Dose-dependent benefits of quercetin on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer |
Q90238282 | Effects of Quercetin-Loaded Nanoparticles on MCF-7 Human Breast Cancer Cells |
Q36085894 | Efficacy of quercetin against chemically induced murine oral squamous cell carcinoma |
Q37382070 | Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea. |
Q34129835 | Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition |
Q42857689 | Ethanolic Extract of Polish Propolis: Chemical Composition and TRAIL-R2 Death Receptor Targeting Apoptotic Activity against Prostate Cancer Cells |
Q42206025 | Extract from mango mistletoes Dendrophthoe pentandra ameliorates TNBS-induced colitis by regulating CD4+ T cells in mesenteric lymph nodes |
Q33838317 | Ficus umbellata Vahl. (Moraceae) Stem Bark Extracts Exert Antitumor Activities In Vitro and In Vivo. |
Q55237274 | Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action. |
Q61448190 | Functional Molecules in Locally-Adapted Crops: The Case Study of Tomatoes, Onions, and Sweet Cherry Fruits From Tuscany in Italy |
Q92131527 | Genome-wide localization of the polyphenol quercetin in human monocytes |
Q35607042 | Greco-arab and islamic herbal-derived anticancer modalities: from tradition to molecular mechanisms |
Q36002545 | Gut microbiota: an Indicator to Gastrointestinal Tract Diseases |
Q33710442 | Improving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems. |
Q55272354 | In Vitro Cytotoxicity and In Vivo Antimammary Tumor Effects of the Hydroethanolic Extract of Acacia seyal (Mimosaceae) Stem Bark. |
Q37361994 | Inhibitory effect of quercetin on epithelial to mesenchymal transition in SK-MEL-28 human melanoma cells defined by in vitro analysis on 3D collagen gels |
Q40156682 | Lipid-core nanocapsules increase the oral efficacy of quercetin in cutaneous leishmaniasis. |
Q34161592 | Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants |
Q28087261 | Natural Compounds Modulating Mitochondrial Functions |
Q37944897 | Nigerian foodstuffs with prostate cancer chemopreventive polyphenols |
Q38119186 | Novel insights into the pharmacology of flavonoids |
Q61813893 | Olive Oil Effects on Colorectal Cancer |
Q40037912 | Oxidative Stress: A Promising Target for Chemoprevention |
Q37469412 | Plant phytochemicals as epigenetic modulators: role in cancer chemoprevention |
Q34305495 | Polyphenols Isolated from Allium cepa L. Induces Apoptosis by Induction of p53 and Suppression of Bcl-2 through Inhibiting PI3K/Akt Signaling Pathway in AGS Human Cancer Cells |
Q26822819 | Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies |
Q57618020 | Preparation and evaluation of 131I-quercetin as a novel radiotherapy agent against dedifferentiated thyroid cancer |
Q64080575 | Progress of Tumor Growth and Metastasis After Inoculation of B16FO Melanoma Cells in Kidney of Female Nude Mice Is Inhibited by a Novel Nutrient Mixture |
Q40492024 | Protection afforded by quercetin against H2O2-induced apoptosis on PC12 cells via activating PI3K/Akt signal pathway |
Q50502702 | Protective effect of total flavonoids of seabuckthorn (Hippophae rhamnoides) in simulated high-altitude polycythemia in rats. |
Q92154927 | Proteomic Analysis of Quercetin-Treated K562 Cells |
Q36116905 | Quantification of mitochondrial reactive oxygen species in living cells by using multi-laser polychromatic flow cytometry |
Q88012496 | Quercetin 3-O-glucoside recovered from the wild Egyptian Sahara plant, Euphorbia paralias L., inhibits glutamine synthetase and has antimycobacterial activity |
Q38860367 | Quercetin 3-O-glucoside suppresses epidermal growth factor-induced migration by inhibiting EGFR signaling in pancreatic cancer cells |
Q89537608 | Quercetin Enhanced Paclitaxel Therapeutic Effects Towards PC-3 Prostate Cancer Through ER Stress Induction and ROS Production |
Q41976627 | Quercetin Regulates Sestrin 2-AMPK-mTOR Signaling Pathway and Induces Apoptosis via Increased Intracellular ROS in HCT116 Colon Cancer Cells |
Q40979812 | Quercetin Reverses Rat Liver Preneoplastic Lesions Induced by Chemical Carcinogenesis. |
Q28071328 | Quercetin and ovarian cancer: An evaluation based on a systematic review |
Q34402813 | Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression. |
Q39333766 | Quercetin enhances hypoxia-mediated apoptosis via direct inhibition of AMPK activity in HCT116 colon cancer |
Q43478898 | Quercetin in cancer prevention and therapy |
Q33844220 | Quercetin induces HepG2 cell apoptosis by inhibiting fatty acid biosynthesis |
Q42271506 | Quercetin induces human colon cancer cells apoptosis by inhibiting the nuclear factor-kappa B Pathway |
Q42120903 | Quercetin inhibited cadmium-induced autophagy in the mouse kidney via inhibition of oxidative stress |
Q41592621 | Quercetin inhibits Cr(VI)-induced malignant cell transformation by targeting miR-21-PDCD4 signaling pathway |
Q38816469 | Quercetin inhibits multiple pathways involved in interleukin 6 secretion from human lung fibroblasts and activity in bronchial epithelial cell transformation induced by benzo[a]pyrene diol epoxide |
Q92319455 | Quercetin modulates signaling pathways and induces apoptosis in cervical cancer cells |
Q28484294 | Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53/Bcl-xl |
Q38987923 | Quercetin potentiates the antitumor activity of rituximab in diffuse large B-cell lymphoma by inhibiting STAT3 pathway |
Q53086639 | Quercetin prevents liver carcinogenesis by inducing cell cycle arrest, decreasing cell proliferation and enhancing apoptosis. |
Q38873724 | Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells |
Q42702654 | Quercetin regresses Dalton's lymphoma growth via suppression of PI3K/AKT signaling leading to upregulation of p53 and decrease in energy metabolism |
Q38619352 | Quercetin regulates the sestrin 2-AMPK-p38 MAPK signaling pathway and induces apoptosis by increasing the generation of intracellular ROS in a p53-independent manner |
Q91627543 | Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway |
Q37403489 | Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis |
Q47149508 | Quercetin-loaded mixed micelles exhibit enhanced cytotoxic efficacy in non-small cell lung cancer in vitro |
Q64929167 | Quercetin: a natural compound for ovarian cancer treatment. |
Q92887290 | ROS-Mediated Cancer Cell Killing through Dietary Phytochemicals |
Q91814747 | Recent Advances in Nanoencapsulation Systems Using PLGA of Bioactive Phenolics for Protection against Chronic Diseases |
Q35220440 | Sensitization to docetaxel in prostate cancer cells by green tea and quercetin |
Q90225264 | Sestrins as a Therapeutic Bridge between ROS and Autophagy in Cancer |
Q38174655 | Site-specific anticancer effects of dietary flavonoid quercetin |
Q28822631 | Structural insights into the polypharmacological activity of quercetin on serine/threonine kinases |
Q42343450 | Synergistic Anticancer Activities of Natural Substances in Human Hepatocellular Carcinoma |
Q47378920 | Synergistic Induction of Apoptosis by Quercetin and Curcumin in Chronic Myeloid Leukemia (K562) Cells. |
Q38844642 | Synergistic effects of snail and quercetin on renal cell carcinoma Caki-2 by altering AKT/mTOR/ERK1/2 signaling pathways. |
Q54403254 | Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells. |
Q47265475 | Telomerase Inhibitors from Natural Products and Their Anticancer Potential |
Q90632887 | The Pharmacological Activity, Biochemical Properties, and Pharmacokinetics of the Major Natural Polyphenolic Flavonoid: Quercetin |
Q92315958 | Thyroid Peroxidase Activity is Inhibited by Phenolic Compounds-Impact of Interaction |
Q26743401 | Tomato as a Source of Carotenoids and Polyphenols Targeted to Cancer Prevention |
Q28487019 | Use of natural products as chemical library for drug discovery and network pharmacology |
Q55089033 | Use of quercetin in animal feed: effects on the P-gp expression and pharmacokinetics of orally administrated enrofloxacin in chicken. |
Q38833891 | Utilizing Zebrafish to Identify Anti-(Lymph)Angiogenic Compounds for Cancer Treatment: Promise and Future Challenges |
Search more.